Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Travera Inc
Eastern Cooperative Oncology Group
NKGen Biotech, Inc.
VA Office of Research and Development
Alliance for Clinical Trials in Oncology